To examine the visual function and thickness of macula to assess function of intravitreal injection of bevacizumab and triamcilone acetonide.
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: H36- Retinal disorders in diseases classified elsewhere
- Registration Number
- CTRI/2020/11/029064
- Lead Sponsor
- Father muller medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Definite retinal thickening resulting from diabetic macular edema on clinical examination involving centre of macula.
Diabetic macular edema confirmed via retinal thickness measured on optical coherence tomography.
Exclusion Criteria
Vitreous haemorrhage.
History of any intraocular surgery/ photocoagulation within previous 3 months.
History of periocular or intraocular drug injection.
Any corneal opacity or cataract which affects pre operative OCT evaluation.
Previous history of glaucoma treatment.
Any other ocular comorbidities that has influence on macular thickness.
Age less than 20 years
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method